News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups
Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups
Hosted by Robert Michel
Sign In

New Twist for Pathology Laboratories: Genetic Cancer Test for Dogs

Mar 24, 2010 | Laboratory News, Laboratory Pathology

OncoPet Diagnostics hopes to create revenue stream while testing human RECAF technology

Genetic cancer testing for dogs is now available. A clinical pathology laboratory in Canada performs the tests on specimens referred by veterinarians. The molecular diagnostics test for dogs uses a blood specimen and can detect 85% of canine cancers. Pre-market studies showed the standard 95% specificity level.

Owners of the 72 million pet dogs in the United States are often as anguished over possible cancer in their dogs as they would be over the possibility of cancer in a human loved one. That is why OncoPet Diagnostics of Richmond, British Columbia, believes the availability of a cheap ($40) cancer test will be welcome news. According to some surveys, about half of dog owners view their pets as members of the family.

(more…)

Spectrum Laboratory Network Sells to Welsh Carson for $230 Million

Dec 16, 2009 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology

Acquisition is a deal between two private equity firms

Spectrum Laboratory Network of Greensboro, North Carolina, will be acquired by Welsh, Carson, Anderson, & Stowe. Investment funds managed by Apax Partners are the sellers and the purchase price is $230 million. It is the highest dollar value acquisition of a clinical laboratory during 2009.

The acquisition agreement was announced at the end of last week. It brings Welsh, Carson back into the laboratory testing industry for the first time since 2007. During this decade, Welsh, Carson held an equity ownership in LabOne, Inc., which was based in Kansas City, Missouri and was building a fast-growing business in medical laboratory testing.

(more…)

;